what they said (Hover the mouse cursor over underlined words for more info)

LONDON -- A British company reported Wednesday that it has achieved the best results ever seen on an experimental human vaccine for avian flu and said mass production might be possible starting next year.
A global health official called GlaxoSmithKline's early results "an exciting piece of science." If future tests are as promising, it would be a major step in the frustrating campaign to protect people from a possible deadly flu pandemic.
The U.S. government's chief infectious disease scientist was also optimistic....

how did it rate? (more information)

what we said (Hover the mouse cursor over underlined words for more info)

This article is based on preliminary data so it is too early to state the benefits and harm of this vaccine. Even when early experimental trials are reported it is useful to explain any adverse effects seen in the trial, how long the results are likely to last, and to include some commentary by outside spokespeople or researchers who are unconnected to the study. In terms of evidence the article doesn't state whether people are actually protected from the flu, only that the vaccine has allowed a certain proportion of them to develop an immune response. It would be useful to know if this translates into real protection or not.

Our sister site in the US reviewed a very similar article from the Wall Street Journal and comes to a very similar review as our own. You can see their review here: http://www.healthnewsreview.org/review/review.php?rid=471

public forum

voice your opinion in the forum

• All comments and feedback submitted to Media Doctor are subject to editorial approval before being made viewable by the public. It may take up to a week for your comments to be approved. Additionally, no response will be given to questions posed in public comments. Media Doctor does not provide medical advice, or answers to medical questions posed by the public.
• If you provide your email address it will not be displayed to the general public.
• Comments may be edited by Media Doctor to remove defamatory or sensitive statements, and brand names.
• Required fields are marked with an asterisk (*).